RNA (STOCKS)
Avidity Biosciences, Inc. Common Stock
$72.875000
-0.015000 (-0.02%)
Prev close: $72.890000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sarah Boyce
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10,985.91M
- Employees
- 391
- P/E (TTM)
- -17.48
- P/B (TTM)
- 5.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
5
Buy
12
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.27 | $-1.11 | -0.1579 | -14.20% |
|
Jun 2025 (Q2)
|
$-1.21 | $-1.00 | -0.2132 | -21.39% |
|
Mar 2025 (Q1)
|
$-0.90 | $-0.91 | +0.0050 | +0.55% |
|
Dec 2024 (Q4)
|
$-0.80 | $-0.80 | -0.0003 | -0.04% |
Financial Statements
| Assets | $2.13B |
| Current Assets | $1.97B |
| Prepaid Expenses | $15.15M |
| Other Current Assets | $1.95B |
| Noncurrent Assets | $168.19M |
| Fixed Assets | $21.50M |
| Other Non-current Assets | $146.69M |
| Liabilities | $247.94M |
| Current Liabilities | $169.88M |
| Accounts Payable | $9.63M |
| Other Current Liabilities | $160.25M |
| Noncurrent Liabilities | $78.07M |
| Equity | $1.89B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.89B |
| Liabilities And Equity | $2.13B |